Immunovant (IMVT)
Developing imeroprubart across six IgG-driven autoimmune diseases.
$37.29
After hours0.00 (0.00%)
At close$37.29(+0.30%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 53.77% | 111.07M shares | |
|---|---|---|---|
| 240 holders · as of Jun 30, 2026 | |||
| Insiders | 1.42% | 2.93M shares | |
| 15 holders · as of Aug 28, 2026 | |||
| Strategic holders | 54.87% | 113.33M shares | |
| 1 holder · as of Dec 12, 2025 | |||
| Adds to | 110.06% | ||
206.55M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 110.06%; nothing is left for Other.
13F, as of Jun 30, 2026
240 holders · 111.07M shares · 41 new positions · 113 increased · 82 reduced · 26 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 16.19M | 7.84% | −761.4K | Aug 13, 2026 |
| Deep Track Capital, LP | 9.34M | 4.52% | −2.19M | Aug 14, 2026 |
| BlackRock, Inc. | 7.18M | 3.48% | +606.4K | Aug 7, 2026 |
| Farallon Capital Management LLC | 5.81M | 2.81% | +4.26M | Aug 14, 2026 |
| Baker Bros. Advisors LP | 5.44M | 2.63% | −22.7K | Aug 14, 2026 |
| State Street Corp | 4.62M | 2.24% | +79.1K | Aug 7, 2026 |
| Morgan Stanley | 4.53M | 2.20% | +658.0K | Aug 13, 2026 |
| TCG Crossover Management, LLC | 4.46M | 2.16% | 0 | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Roivant Sciences Ltd. | 55.90% | 113.33M | 13D | Dec 12, 2025 |
| FMR LLC | 8.40% | 14.73M | 13G | Nov 5, 2025 |
| Deep Track Capital, LP | 5.59% | 9.50M | 13G | Mar 26, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 28, 2026 | Atul Pandedirector | Sale | 1,500 | $43.27 | 116,731 |
| Aug 20, 2026 | Melanie Gloriaofficer: Chief Operating Officer | Sale | 3,056 | $44.16 | 219,301 |
| Jul 23, 2026 | Jay S. Stoutofficer: Chief Technology Officer | Sale | 2,857 | $38.69 | 205,341 |
| Jul 23, 2026 | Tiago Giraoofficer: Chief Financial Officer | Sale | 6,798 | $38.69 | 240,798 |
| Jul 24, 2026 | Atul Pandedirector | Sale | 1,500 | $39.80 | 116,731 |
| Jul 8, 2026 | Jay S. Stoutofficer: Chief Technology Officer | Sale · 4 lots | 3,487 | $39.55 | 208,198 |
| Jul 8, 2026 | Christopher van Tuylofficer: Chief Legal Officer | Sale · 2 lots | 1,206 | $39.55 | 179,391 |
| Jul 8, 2026 | Melanie Gloriaofficer: Chief Operating Officer | Sale · 2 lots | 2,036 | $39.55 | 222,357 |
| Jul 2, 2026 | Eric Venkerdirector, officer: Chief Executive Officer | Sale | 3,092 | $38.48 | 254,280 |
| Jun 26, 2026 | Atul Pandedirector | Sale | 1,500 | $38.01 | 116,731 |
House and Senate disclosures
Not reported.